P

PubMedAI

EVE Evidence Analyzer

Patent Pending

1 5 Isoquinolinesulfonyl 2 Methylpiperazine

A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.

300 PubMed studies analyzed
Loading evidence profile...

This evidence profile for 1 5 Isoquinolinesulfonyl 2 Methylpiperazine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.